InvestorsObserver
×
News Home

Is Pear Therapeutics Inc (PEAR) a Leader in the Health Information Services Industry?

Monday, March 27, 2023 12:44 PM | InvestorsObserver Analysts

Mentioned in this article

Is Pear Therapeutics Inc (PEAR) a Leader in the Health Information Services Industry?

The 32 rating InvestorsObserver gives to Pear Therapeutics Inc (PEAR) stock puts it near the bottom of the Health Information Services industry. In addition to scoring higher than 27 percent of stocks in the Health Information Services industry, PEAR’s 32 overall rating means the stock scores better than 32 percent of all stocks.

Overall Score - 32
PEAR has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on PEAR!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Pear Therapeutics Inc Stock Today?

Pear Therapeutics Inc (PEAR) stock is down -8.87% while the S&P 500 is higher by 0.19% as of 12:43 PM on Monday, Mar 27. PEAR is down -$0.03 from the previous closing price of $0.29 on volume of 629,884 shares. Over the past year the S&P 500 is down -13.04% while PEAR is down -93.87%. PEAR lost -$0.89 per share the over the last 12 months. Click Here to get the full Stock Report for Pear Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App